Zak Mir interviews Peter Francis, Non-Executive Chairman of ADM Energy
Click the play button below to listen to the audio.
1 – We note the 14th lifting at the Aje field RNS on Monday – when can investors expect the next one?
2 – Can you elaborate on the partner’s plans for Aje in 2021.
3 – The closure of the EER deal with stock vesting at the 7p level has been trailed within that same RNS Monday – is it safe to assume investors can expect news on this shortly?
4 – At the recent investor Q&A session a number of potential deals were hinted at that were intimated to be a major step forward for the Company – when can investors anticipate an update here?
5 – Can you confirm the company has adequate funding at present to carry out its plans without recourse to equity investors?
6 – On an Enterprise Value to 2P basis the shares trade at a massive discount to peers – why is this and when can they expect a meaningful re-rate?
7 – Finally, do you have any other message to ADM shareholders at this point?
To read our recent coverage on ADM Energy CLICK HERE
ADM Energy is a research client of Align Research. Both Align Research & a Director of Align Research hold an interest in the shares of ADM Energy.and are bound to Align Research’s company dealing policy ensuring open and adequate disclosure. Full details can be found on our website here (“Legals”).
This is a marketing communication and cannot be considered independent research nor is it subject to any prohibition on dealing ahead of its dissemination. Nothing in this report should be construed as advice, an offer, or the solicitation of an offer to buy or sell securities by us. As we have no knowledge of your individual situation and circumstances the investment(s) covered may not be suitable for you. You should not make any investment decision without consulting a fully qualified financial advisor.
Your capital is at risk by investing in securities and the income from them may fluctuate. Past performance is not necessarily a guide to future performance and forecasts are not a reliable indicator of future results. The marketability of some of the companies we cover is limited and you may have difficulty buying or selling in volume. Additionally, given the smaller capitalisation bias of our coverage, the companies we cover should be considered as high risk
This financial promotion has been approved by Align Research Limited